Search Within

Melanie Fanny Chen

Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Breast Medicine Service (6)
  2. Department of Medicine (6)
  3. Solid Tumor Oncology Division (6)
  4. Biostatistics Service (5)
  5. Epidemiology and Biostatistics (5)
  6. Population Sciences Research Program (5)

More Groups

People
  1. Chau Dang (5)
  2. Clifford Hudis (5)
  3. Sujata Patil (5)
  4. Elizabeth Comen (4)
  5. Neil Iyengar (4)
  6. Tiffany Traina (4)

More People

Years
  1. 2016 (3)
  2. 2014 (2)
  3. 2013 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Breast Cancer Research and Treatment (1)
  3. Cancer Research (1)
  4. Clinical Breast Cancer (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. Springer (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: Overall survival and updated progression-free survival results from a phase II study
    Journal Article

    Smyth, L. M.; Iyengar, N. M.; Chen, M. F.; Popper, S. M.; Patil, S.; Wasserheit-Lieblich, C.; Argolo, D. F.; Singh, J. C.; Chandarlapaty, S.; Sugarman, S. M.; more...
    Breast Cancer Research and Treatment (2016)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab in the treatment of metastatic HER2-positive breast cancer after prior trastuzumab/pertuzumab- or pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Argolo, D.; Smyth, L.; Chen, M. F.; Hudis, C. A.; Dang, C. T.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer
    Journal Article

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K. L.; Patil, S.; Chen, M.; Mcdonnell, E.; Neville, D. A.; Mak, F. M.; Gansukh, B.; Humm, J. L.; Holodny, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save